Login / Signup

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

Rui XiongLeike ZhangShiliang LiYuan SunMinyi DingYong WangYongliang ZhaoYan WuWeijuan ShangXiaming JiangJiwei ShanZihao ShenYi TongLiuxin XuYu ChenYingle LiuGang ZouDimitri LavilletteZhenjiang ZhaoRui WangLili ZhuGengfu XiaoKe LanHongLin LiKe Xu
Published in: Protein & cell (2020)
In the original publication the author's name 'Dimitri Lavillete' is published incorrectly. The correct author name should be spelt as 'Dimitri Lavillette' is provided in this correction.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • cancer therapy
  • anti inflammatory
  • randomized controlled trial
  • systematic review
  • nucleic acid